Specific Residues in the 2009 H1N1 Swine-Origin Influenza Matrix Protein Influence Virion Morphology and Efficiency of Viral Spread In Vitro

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Bialas, Kristy M ^a   Desmet, Emily A ^a,b   Takimoto, Toru ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; PROTEIN M1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRION; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS STRAIN; VIRUS TITRATION; VIRUS TRANSMISSION;

ANIMALS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICROSCOPY, ELECTRON; SWINE; VIRAL MATRIX PROTEINS; VIRION;

ORTHOMYXOVIRIDAE; SUIDAE;

EID: 84870276860     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050595     Document Type: Article

References (49)

1. Palese P, Shaw M (2007) Orthomyxoviridae: The Viruses and Their Replication; Knipe DM, Howley PM, editors. Philadelphia, PA: Lippincott Williams & Wilkins.
2. Fauci AS, (2006) Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act. Cell 124: 665-670.
3. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
4. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
5. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans. New England Journal of Medicine 360: 2605-2615.
6. Newman AP, Reisdorf E, Beinemann J, Uyeki TM, Balish A, et al. (2008) Human case of swine influenza A (H1N1) triple reassortant virus infection, Wisconsin. Emerg Infect Dis 14: 1470-1472.
7. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, et al. (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 360: 2616-2625.
8. Nayak DP, Hui EK, Barman S, (2004) Assembly and budding of influenza virus. Virus Res 106: 147-165.
9. Lakdawala SS, Lamirande EW, Suguitan AL Jr, Wang W, Santos CP, et al. (2011) Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog 7: e1002443.
10. Enami M, Enami K, (1996) Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J Virol 70: 6653-6657.
11. Jin H, Leser GP, Zhang J, Lamb RA, (1997) Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. Embo J 16: 1236-1247.
12. Ali A, Avalos RT, Ponimaskin E, Nayak DP, (2000) Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J Virol 74: 8709-8719.
13. Ye Z, Liu T, Offringa DP, McInnis J, Levandowski RA, (1999) Association of influenza virus matrix protein with ribonucleoproteins. J Virol 73: 7467-7473.
14. Baudin F, Petit I, Weissenhorn W, Ruigrok RW, (2001) In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology 281: 102-108.
15. Noton SL, Medcalf E, Fisher D, Mullin AE, Elton D, et al. (2007) Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol 88: 2280-2290.
16. Yasuda J, Nakada S, Kato A, Toyoda T, Ishihama A, (1993) Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology 196: 249-255.
17. Akarsu H, Burmeister WP, Petosa C, Petit I, Muller CW, et al. (2003) Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). Embo J 22: 4646-4655.
18. Bui M, Wills EG, Helenius A, Whittaker GR, (2000) Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol 74: 1781-1786.
19. Huang X, Liu T, Muller J, Levandowski RA, Ye Z, (2001) Effect of influenza virus matrix protein and viral RNA on ribonucleoprotein formation and nuclear export. Virology 287: 405-416.
20. Chou YY, Albrecht RA, Pica N, Lowen AC, Richt JA, et al. (2011) The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol 85: 11235-11241.
21. Fujiyoshi Y, Kume NP, Sakata K, Sato SB, (1994) Fine structure of influenza A virus observed by electron cryo-microscopy. Embo J 13: 318-326.
22. Bourmakina SV, Garcia-Sastre A, (2003) Reverse genetics studies on the filamentous morphology of influenza A virus. J Gen Virol 84: 517-527.
23. Elleman CJ, Barclay WS, (2004) The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321: 144-153.
24. Burleigh LM, Calder LJ, Skehel JJ, Steinhauer DA, (2005) Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes. J Virol 79: 1262-1270.
25. Chu CM, Dawson IM, Elford WJ, (1949) Filamentous forms associated with newly isolated influenza virus. Lancet 1: 602.
26. Kilbourne ED, Murphy JS, (1960) Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8. J Exp Med 111: 387-406.
27. Choppin PW, Murphy JS, Tamm I, (1960) Studies of two kinds of virus particles which comprise influenza A2 virus strains. III. Morphological characteristics: independence to morphological and functional traits. J Exp Med 112: 945-952.
28. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
29. Nakajima N, Hata S, Sato Y, Tobiume M, Katano H, et al. (2010) The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examination. Jpn J Infect Dis 63: 67-71.
30. Roberts PC, Lamb RA, Compans RW, (1998) The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240: 127-137.
31. Liu T, Muller J, Ye Z, (2002) Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology. Virology 304: 89-96.
32. McCown MF, Pekosz A, (2006) Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. J Virol 80: 8178-8189.
33. Iwatsuki-Horimoto K, Horimoto T, Noda T, Kiso M, Maeda J, et al. (2006) The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol 80: 5233-5240.
34. Noton SL, Simpson-Holley M, Medcalf E, Wise HM, Hutchinson EC, et al. (2009) Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virions. J Virol 83: 562-571.
35. Rossman JS, Jing X, Leser GP, Balannik V, Pinto LH, et al. (2010) Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J Virol 84: 5078-5088.
36. Lai JC, Chan WW, Kien F, Nicholls JM, Peiris JS, et al. (2010) Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase. J Gen Virol 91: 2322-2330.
37. Wang D, Harmon A, Jin J, Francis DH, Christopher-Hennings J, et al. (2010) The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles. J Virol 84: 4673-4681.
38. Rossman JS, Jing X, Leser GP, Lamb RA, (2010) Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 142: 902-913.
39. WHO (2010) WHO Global Alert and Response: Pandemic (H1N1) 2009- update 101, weekly update.
40. Sorrell EM, Schrauwen EJ, Linster M, De Graaf M, Herfst S, et al. (2011) Predicting 'airborne' influenza viruses: (trans-) mission impossible? Curr Opin Virol 1: 635-642.
41. Tellier R, (2006) Review of aerosol transmission of influenza A virus. Emerg Infect Dis 12: 1657-1662.
42. Rossman JS, Lamb RA, (2011) Influenza virus assembly and budding. Virology 411: 229-236.
43. Zhang J, Leser GP, Pekosz A, Lamb RA, (2000) The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging. Virology 269: 325-334.
44. Chen BJ, Leser GP, Jackson D, Lamb RA, (2008) The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol 82: 10059-10070.
45. Leser GP, Lamb RA, (2005) Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology 342: 215-227.
46. Schmitt AP, Lamb RA, (2005) Influenza virus assembly and budding at the viral budozone. Adv Virus Res 64: 383-416.
47. Calder LJ, Wasilewski S, Berriman JA, Rosenthal PB, (2010) Structural organization of a filamentous influenza A virus. Proc Natl Acad Sci U S A 107: 10685-10690.
48. Bussey KA, Bousse TL, Desmet EA, Kim B, Takimoto T, (2010) PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. J Virol 84: 4395-4406.
49. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, et al. (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96: 9345-9350.